Clopidogrel Response in Acute Ischemic Stroke. The Bochumer CRISP Study

Ruhr University of Bochum159 enrolled

Overview

The aim of this study was to determine the prevalence rate and risk factors for chemical laboratory clopidogrel low-response (CLR) in the acute phase after an ischemic stroke.

Study Type

OBSERVATIONAL

Enrollment

159

Conditions

Ischemic Stroke

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * acute ischemic stroke * admittance to stroke unit * clopidogrel medication Exclusion Criteria: * no consent * prior bleeding disorders * severe liver disorders * current gastrointestinal disorders * congestive heart failure * life-threatening malignancies

Locations (1)

Department of Neurology, Ruhr University Bochum

Bochum, Germany

Outcomes

Primary Outcomes

Result of platelet function test

Aggregometry result of antiplatelet therapy

Time frame: one day

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.